Form 4: Nuvation Bio Inc. Executive Colleen Sjogren Reports Stock Option Grant

Colleen Sjogren, Chief Commercial Officer of Nuvation Bio Inc., reports the acquisition of stock options for 750,000 shares of Class A Common Stock.

Summary

• Colleen Sjogren, Chief Commercial Officer of Nuvation Bio Inc., filed a Form 4 on April 11, 2024, reporting transactions related to Nuvation Bio Inc. [NUVB].
• On April 9, 2024, Sjogren acquired options to purchase 500,000 shares of Class A Common Stock at an exercise price of $3.23.
• These options vest as to 25% on the one-year anniversary of March 27, 2024, and then monthly over the following 36 months, contingent upon continuous service.
• Additionally, Sjogren acquired options to purchase 250,000 shares of Class A Common Stock at an exercise price of $3.23.
• The vesting of these 250,000 shares is subject to both time-based and performance-based criteria.
• Following these transactions, Sjogren directly owns options for 750,000 shares of Nuvation Bio Inc. Class A Common Stock.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it aligns management incentives with shareholder value. The vesting schedule suggests a long-term commitment.

Positives

• The grant of stock options to the Chief Commercial Officer aligns her interests with those of the shareholders.
• The vesting schedule encourages long-term commitment and performance.

Industry Context

Stock options are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders by incentivizing them to increase the company's stock value.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for executives in publicly traded biotechnology companies.
• Companies like Amgen, Gilead Sciences, and Biogen also utilize stock options to incentivize their executives.
• The vesting schedules and exercise prices are generally aligned with industry norms to retain talent and drive performance.

Stakeholder Impact

• Shareholders: Potential for increased stock value if the executive's performance drives company success.
• Employees: May see the executive's compensation as a sign of confidence in the company's future.
• Executive: Incentivized to improve company performance to realize value from the stock options.

Key Dates